Hacker News
- Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/ 270 comments
- Oral Molnupiravir reduces hospitalization and mortality of COVID-19 by 50% https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/ 62 comments science
Linking pages
- A new antiviral pill cuts COVID-19 hospitalization and death rates https://www.sciencenews.org/article/coronavirus-covid-antiviral-pill-merck-molnupiravir-hospitalization-death 460 comments
- How Will the COVID Pills Change the Pandemic? | The New Yorker https://www.newyorker.com/science/medical-dispatch/how-will-the-covid-pills-change-the-pandemic 53 comments
- 55 Percent of Police Killings Are Misclassified as Other Causes of Death https://reason.com/2021/10/01/55-percent-of-police-killings-are-misclassified-as-other-causes-of-death/ 53 comments
- A New COVID-19 Pill Reportedly Cuts Hospitalizations and Deaths by Half https://interestingengineering.com/new-covid-19-pill-reportedly-cuts-hospitalizations-and-deaths-by-half 51 comments
- Covid News: U.S. Parents’ Views Are Shifting on Vaccines - The New York Times https://www.nytimes.com/2021/10/01/us/merck-antiviral-pill-covid.html 32 comments
- A che punto siamo sui farmaci per curare la Covid-19 - Facta https://facta.news/storie/2021/11/23/a-che-punto-siamo-sui-farmaci-per-curare-la-covid-19/ 28 comments
- Ivermectin--Upon Neutral Ground - by Steven Phillips, MD https://zerospin.substack.com/p/ivermectin-upon-neutral-ground?s=r 5 comments
- The Cult of the Vaccine - TK News by Matt Taibbi https://taibbi.substack.com/p/the-cult-of-the-vaccine-neurotic 3 comments
- Molnupiravir for Covid-19 in Nonhospitalized Patients | NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2201612 0 comments
- Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment https://www.forbes.com/sites/jacquelinebryant/2021/11/13/canadian-biotech-known-for-psilocybin-and-cannabinoid-based-medicines-in-fda-phase-3-trial-for-bucillamine-based-oral-covid-treatment/ 0 comments